Drug absorption: cardenolide: AUC (µg × L/h) · first aid in patients with acute oral poisoning (carbamazepine, yellow oleander, or combinations of different drugs)
1 finding from 1 review
Hospitalization · first aid in patients with acute oral poisoning (carbamazepine, yellow oleander, or combinations of different drugs)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of admissions to the ICU · first aid in patients with acute oral poisoning (carbamazepine, yellow oleander, or combinations of different drugs)
MDAC + hospital intervention may leads to lower incidence of ICU admission compared with SDAC + hospital intervention (low certainty).
1 finding from 1 review
Incidence of mortality · first aid in patients with acute oral poisoning (benzodiazepines, yellow oleander or combinations of different drugs)
MDAC + hospital intervention showed no clear difference in incidence of mortality compared with hospital intervention (low certainty).
1 finding from 1 review
Incidence of adverse events · first aid in patients with acute oral poisoning (benzodiazepines, yellow oleander or combinations of different drugs)
MDAC + hospital intervention showed no clear difference in incidence of adverse events compared with hospital intervention (low certainty).
1 finding from 1 review
Incidence and severity of symptoms of poisoning: incidence of need for intubation · first aid in patients with acute oral poisoning (benzodiazepines, yellow oleander or combinations of different drugs)
MDAC + hospital intervention showed no clear difference in incidence and severity of symptoms of poisoning: incidence of need… compared with hospital intervention (low certainty).
1 finding from 1 review
Duration of intubation · first aid in patients with acute oral poisoning (benzodiazepines, yellow oleander or combinations of different drugs)
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Low
Drug absorption: cardenolide: AUC (µg/L × h) · first aid in patients with acute oral poisoning (benzodiazepines, yellow oleander or combinations of different drugs)
1 finding from 1 review
Hospitalization · first aid in patients with acute oral poisoning (benzodiazepines, yellow oleander or combinations of different drugs)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of admissions to the ICU · first aid in patients with acute oral poisoning (benzodiazepines, yellow oleander or combinations of different drugs)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of mortality · first aid in patients with acute oral poisoning (not specified, tricyclic antidepressants, combinations of different drugs or yellow…
SDAC + hospital intervention showed no clear difference in incidence of mortality compared with hospital intervention alone (low certainty).
1 finding from 1 review
Incidence of adverse events · first aid in patients with acute oral poisoning (not specified, tricyclic antidepressants, combinations of different drugs or yellow…
1 finding from 1 review
Retention rates, 12 months, Cohort 1 Scale from: 0 to 100. · Teachers
1 finding from 1 review
Retention rates, 24 months, Cohort 1 Scale from: 0 to 100. · Teachers
1 finding from 1 review
Retention rates, 36 months, Cohort 1 Scale from: 0 to 100. · Teachers
1 finding from 1 review
Adherence to pharmacotherapy: number of people completing treatment · COPD
Single component intervention showed no clear difference in adherence to pharmacotherapy: number of people completing treatment compared with control (low certainty).
1 finding from 1 review
Quality of life: SGRQ total or CCQ · COPD
1 finding from 1 review
Hospital admissions · COPD
It is very uncertain whether single component intervention changes hospital service utilisation: number of people admitted to hospital… compared with control (very low certainty).
1 finding from 1 review
Exacerbations (number of people experiencing ≥ 1 exacerbations) · COPD
It is very uncertain whether single component intervention changes exacerbations: number of people experiencing exacerbations compared with control (very low certainty).
1 finding from 1 review
Adverse events: number of people experiencing adverse events (all cause or COPD‐related), serious adverse events, mortality · COPD
It is very uncertain whether single component intervention changes adverse events: number of people experiencing adverse events (all… compared with control (very low certainty).
1 finding from 1 review